Concord Healthcare Group Co., Ltd. (CONCORD HC GP) has filed its Monthly Return for the period ended 30 September 2026, confirming a steady capital structure with no changes to either Hong Kong-listed H shares or unlisted domestic shares during the month.

Key disclosures:

1. Issued Share Capital • H shares outstanding remained at 313.87 million (par value: RMB 1 each). • Domestic shares stood unchanged at 469.79 million (par value: RMB 1 each). • Total issued share capital therefore held at 783.66 million shares.

2. Public Float Compliance • The company affirmed compliance with the Main Board’s minimum 25% public-float requirement for its H shares as at 30 September 2026.

3. Treasury Shares • Concord reported zero treasury shares at both the beginning and end of the month; no repurchases or cancellations occurred.

4. Convertible Bonds • Outstanding 2% convertible bonds due 2027 totalled HKD 68.00 million, carrying a conversion price of HKD 1.70 per H share. • No conversions took place in September; up to 40.00 million new H shares (equivalent to roughly 12.7% of existing H-share count) could still be issued upon full conversion.

5. Absence of Other Dilutive Instruments • The company has no outstanding share option schemes, warrants, or other equity-linked agreements reported for the month.

Overall, Concord’s September return indicates capital stability, with future equity dilution contingent primarily on the potential conversion of its HKD 68.00 million 2% convertible bonds maturing in 2027.